Ever Source Wealth Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 115 shares of RXRX stock, worth $882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115Holding current value
$882% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$261 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$248 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$191 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$133 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$112 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.38B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...